Jennifer Bush
CIK: 0001621152
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Artiva Biotherapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- Nov 2, 2026ARTV
Artiva Biotherapeutics, Inc.
Sale(S)Direct8.4K shares at avg. $4.18$35K - Oct 5, 2026ARTV
Artiva Biotherapeutics, Inc.
Sale(S)Direct8.4K shares at avg. $6.84$57K - Sep 9, 2026ARTV
Artiva Biotherapeutics, Inc.
Award(A)Direct45K shares- - Sep 3, 2026ARTV
Artiva Biotherapeutics, Inc.
Sale(S)Direct8.4K shares at avg. $11.16$94K - May 19, 2026ARTV
Artiva Biotherapeutics, Inc.
Sale(S)Direct8.8K shares at avg. $9.01$79K - Feb 15, 2026ARTV
Artiva Biotherapeutics, Inc.
Tax Payment(F)Direct3.5K shares at avg. $4.00$14K - Feb 15, 2026ARTV
Artiva Biotherapeutics, Inc.
Award(A)Direct117.3K shares- - Dec 12, 2025ARTV
Artiva Biotherapeutics, Inc.
Disposition(D)DirectEmployee Stock Option (Right to Buy)
20.5K shares- - Dec 12, 2025ARTV
Artiva Biotherapeutics, Inc.
Award(A)Direct84.9K shares- - Dec 12, 2025ARTV
Artiva Biotherapeutics, Inc.
Disposition(D)DirectEmployee Stock Option (Right to Buy)
41K shares- - Dec 12, 2025ARTV
Artiva Biotherapeutics, Inc.
Disposition(D)DirectEmployee Stock Option (Right to Buy)
9.1K shares- - Dec 12, 2025ARTV
Artiva Biotherapeutics, Inc.
Disposition(D)DirectEmployee Stock Option (Right to Buy)
14.2K shares- - Nov 15, 2025ARTV
Artiva Biotherapeutics, Inc.
Tax Payment(F)Direct3.1K shares at avg. $3.25$10K - Aug 15, 2025ARTV
Artiva Biotherapeutics, Inc.
Tax Payment(F)Direct6.4K shares at avg. $2.75$18K - May 15, 2025ARTV
Artiva Biotherapeutics, Inc.
Tax Payment(F)Direct1.9K shares at avg. $2.13$4K - Feb 26, 2025ARTV
Artiva Biotherapeutics, Inc.
Award(A)Direct86.7K shares- - Sep 12, 2024ARTV
Artiva Biotherapeutics, Inc.
Award(A)Direct50K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Nov 2, 2026 | ARTV Artiva Biotherapeutics, Inc. | Sale(S) | 8,439 | $4.18 | $35,284 | Direct |
| Oct 5, 2026 | ARTV Artiva Biotherapeutics, Inc. | Sale(S) | 8,370 | $6.84 | $57,227 | Direct |
| Sep 9, 2026 | ARTV Artiva Biotherapeutics, Inc. | Award(A) | 45,000 | - | $0 | Direct |
| Sep 3, 2026 | ARTV Artiva Biotherapeutics, Inc. | Sale(S) | 8,391 | $11.16 | $93,606 | Direct |
| May 19, 2026 | ARTV Artiva Biotherapeutics, Inc. | Sale(S) | 8,790 | $9.01 | $79,179 | Direct |
| Feb 15, 2026 | ARTV Artiva Biotherapeutics, Inc. | Tax Payment(F) | 3,515 | $4.00 | $14,060 | Direct |
| Feb 15, 2026 | ARTV Artiva Biotherapeutics, Inc. | Award(A) | 117,300 | - | $0 | Direct |
| Dec 12, 2025 | ARTV Artiva Biotherapeutics, Inc. | Disposition(D) Employee Stock Option (Right to Buy) | 20,519 | - | - | Direct |
| Dec 12, 2025 | ARTV Artiva Biotherapeutics, Inc. | Award(A) | 84,877 | - | - | Direct |
| Dec 12, 2025 | ARTV Artiva Biotherapeutics, Inc. | Disposition(D) Employee Stock Option (Right to Buy) | 41,039 | - | - | Direct |
| Dec 12, 2025 | ARTV Artiva Biotherapeutics, Inc. | Disposition(D) Employee Stock Option (Right to Buy) | 9,119 | - | - | Direct |
| Dec 12, 2025 | ARTV Artiva Biotherapeutics, Inc. | Disposition(D) Employee Stock Option (Right to Buy) | 14,202 | - | - | Direct |
| Nov 15, 2025 | ARTV Artiva Biotherapeutics, Inc. | Tax Payment(F) | 3,055 | $3.25 | $9,929 | Direct |
| Aug 15, 2025 | ARTV Artiva Biotherapeutics, Inc. | Tax Payment(F) | 6,409 | $2.75 | $17,625 | Direct |
| May 15, 2025 | ARTV Artiva Biotherapeutics, Inc. | Tax Payment(F) | 1,937 | $2.13 | $4,126 | Direct |
| Feb 26, 2025 | ARTV Artiva Biotherapeutics, Inc. | Award(A) | 86,650 | - | - | Direct |
| Sep 12, 2024 | ARTV Artiva Biotherapeutics, Inc. | Award(A) | 50,000 | - | $0 | Direct |
1-17 of 17 transactions
About Bush Jennifer
Bush Jennifer (SEC CIK 0001621152) files insider reports with the SEC as COO, CLO, Compliance Officer of Artiva Biotherapeutics, Inc. (ARTV).
Signal8 holds 11 ownership filings by Bush Jennifer, all Form 4s, filed between Sep 13, 2024 and Nov 3, 2026. Those filings report 17 transactions, from Sep 12, 2024 to Nov 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Bush Jennifer's filings is in SAN DIEGO, CA.
Recent filings by Bush Jennifer
- Nov 2, 2026: Open-market sale of ARTV shares (Form 4, code S).
- Oct 5, 2026: Open-market sale of ARTV shares (Form 4, code S).
- Sep 9, 2026: Grant or award of ARTV shares (Form 4, code A).
- Sep 3, 2026: Open-market sale of ARTV shares (Form 4, code S).
- May 19, 2026: Open-market sale of ARTV shares (Form 4, code S).
Other insiders filing for Artiva Biotherapeutics, Inc. (ARTV)
- Horan Christopher, Chief Tech Operations Officer
- Banerjee Subhashis, Chief Medical Officer
- Aslan Fred, Chief Executive Officer
- RA CAPITAL MANAGEMENT, L.P., Director
- Stoppel Laura, Director
- Sorg Elaine K., Director